Fundamentals/news are improving (strong Q4 print + dividend), but the near-term setup looks more like wait/hold than an aggressive chase at $27.94.
No notable hedge fund/insider accumulation signals and no congress trading read-through to reinforce a “buy now” decision.
Technical Analysis
Trend (MAs): Bullish structure with SMA_5 > SMA_20 > SMA_200, indicating an uptrend bias.
Momentum: MACD histogram -0.0508 (below 0) but negatively contracting → downside momentum is easing, not a fresh upside thrust.
RSI: RSI_6 52.1 (neutral) → no overbought/oversold edge.
Levels: Pivot 27.77 (price 27.94 slightly above pivot). Near resistance R1 28.94; support S1 26.60.
Pattern-based outlook: Similar-candlestick study shows ~70% chance of +1.44% next day, but -6.83% over next month → short-term pop risk but weaker 1-month expectancy.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Open Interest Put/Call = 4.4: heavy put open interest vs calls → cautious/defensive positioning (hedging or bearish skew).
Option Volume Put/Call = 0.0 and today’s option volume = 0: sentiment is hard to confirm via flow today (little/no trading activity).
Implied vol (30d) 23.9 vs historical vol 34.98 and IV percentile ~0.4: options are priced relatively cheaply vs realized; not signaling panic, but also not signaling strong demand for upside calls.
Technical Summary
Sell
1
Buy
11
Positive Catalysts
Q4 2025 earnings strength: GAAP EPS $0.75, revenue $110.3M with ~69.8% YoY increase reported in news.
Financial momentum: snapshot shows Revenue +65.96% YoY, Net Income +102.09% YoY, EPS +53.06% YoY (2025/Q4).
Dividend: declared $0.18 quarterly (supports total return, signals capital stability).
Scale narrative: acquisition integration/scale benefits highlighted by analysts as profitability improves.
Wall Street pros: improving profitability, scale benefits from acquisition, earnings momentum, dividend support.
Wall Street cons: near-term trading setup not screaming “must-buy now”; options market skew implies caution/hedging despite good fundamentals.
Wall Street analysts forecast CNOB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNOB is 28 USD with a low forecast of 28 USD and a high forecast of 28 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast CNOB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNOB is 28 USD with a low forecast of 28 USD and a high forecast of 28 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 27.770
Low
28
Averages
28
High
28
Current: 27.770
Low
28
Averages
28
High
28
Keefe Bruyette
Outperform
maintain
$30 -> $32
AI Analysis
2026-01-30
Reason
Keefe Bruyette
Price Target
$30 -> $32
AI Analysis
2026-01-30
maintain
Outperform
Reason
Keefe Bruyette raised the firm's price target on ConnectOne Bancorp to $32 from $30 and keeps an Outperform rating on the shares.
Piper Sandler
Overweight
initiated
$28
2025-11-07
Reason
Piper Sandler
Price Target
$28
2025-11-07
initiated
Overweight
Reason
Piper Sandler assumed coverage of ConnectOne Bancorp with an Overweight rating and $28 price target. The firm believes the company's acquisition of First of Long Island Corporation is providing "much-needed scale." ConnectOne's profitability levels continue to move higher, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CNOB
